Compare Dynatrace Inc. Common Stock (DT) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dynatrace Inc. Common Stock vs Immunovant Inc. Common Stock — how do they compare? Dynatrace Inc. Common Stock trades at $63.35 (market cap $17.66B), while Immunovant Inc. Common Stock trades at $30.36 (market cap $6.25B). The key difference: Dynatrace Inc. Common Stock is far larger — about 2.8× Immunovant Inc. Common Stock's market cap, and Dynatrace Inc. Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dynatrace Inc. Common Stock for 1 Days and Immunovant Inc. Common Stock for 1 Days on average.
| DT | IMVT | |
|---|---|---|
Market Cap | $17.66B | $6.25B |
Volume | 8,779,681 | 1,755,411 |
Sector | Technology | Health |
52-Week High | $61.12 | $44.96 |
52-Week Low | $32.36 | $17.03 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $16.71B | $5.35B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dynatrace Inc. Common Stock
Dynatrace provides an observability, security, and automation platform for cloud and IT environments. Its platform integrates data such as logs, metrics, and traces to help organizations monitor digital systems.
Read more on DT →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
